Total Payments
$125,288
2024 Payments
$26,872
Companies
7
Transactions
73
Medicare Patients
1,585
Medicare Billing
$170,547
Payment Breakdown by Category
Consulting$74,022 (59.1%)
Other$26,300 (21.0%)
Travel$22,870 (18.3%)
Food & Beverage$2,096 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $74,022 | 14 | 59.1% |
| Travel and Lodging | $22,870 | 31 | 18.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,300 | 2 | 12.2% |
| Honoraria | $11,000 | 5 | 8.8% |
| Food and Beverage | $2,096 | 21 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $63,009 | 22 | $0 (2023) |
| Octapharma USA, Inc. | $24,079 | 18 | $0 (2024) |
| Genentech USA, Inc. | $19,950 | 22 | $0 (2024) |
| GENZYME CORPORATION | $14,235 | 6 | $0 (2024) |
| PFIZER INC. | $2,500 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,136 | 1 | $0 (2024) |
| Genentech, Inc. | $378.88 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,872 | 23 | Octapharma USA, Inc. ($12,991) |
| 2023 | $68,407 | 38 | Takeda Pharmaceuticals U.S.A., Inc. ($40,119) |
| 2022 | $30,009 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($22,890) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $148.59 | General |
| 11/15/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: COAGULATION | ||||||
| 11/15/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $522.25 | General |
| Category: COAGULATION | ||||||
| 11/15/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $472.35 | General |
| Category: COAGULATION | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Consulting Fee | Cash or cash equivalent | $5,310.00 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Travel and Lodging | In-kind items and services | $577.26 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $148.08 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $110.77 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Travel and Lodging | Cash or cash equivalent | $98.42 | General |
| Category: Hematology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $86.19 | General |
| Category: Hematology | ||||||
| 09/28/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $7,959.00 | General |
| Category: COAGULATION | ||||||
| 09/28/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: COAGULATION | ||||||
| 09/28/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $417.72 | General |
| Category: COAGULATION | ||||||
| 09/28/2024 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Travel and Lodging | Cash or cash equivalent | $119.41 | General |
| Category: COAGULATION | ||||||
| 09/12/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $149.32 | General |
| Category: Hematology | ||||||
| 06/24/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $67.21 | General |
| Category: Hematology | ||||||
| 06/13/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,157.00 | General |
| 06/13/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $36.78 | General |
| 05/13/2024 | Genentech, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $146.43 | General |
| Category: Hematology | ||||||
| 05/09/2024 | PFIZER INC. | BEQVEZ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: HEMATOLOGY | ||||||
| 04/21/2024 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $89.30 | General |
| Category: Hematology | ||||||
| 03/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Jivi (Drug) | Consulting Fee | Cash or cash equivalent | $1,136.00 | General |
| Category: Hematology | ||||||
| 12/08/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $10,904.00 | General |
| 12/08/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $176.55 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 167 | 493 | $85,938 | $16,871 |
| 2022 | 6 | 392 | 1,069 | $208,603 | $43,253 |
| 2021 | 8 | 561 | 1,338 | $287,334 | $60,748 |
| 2020 | 9 | 465 | 1,024 | $223,695 | $49,674 |
Total Patients
1,585
Total Services
3,924
Medicare Billing
$170,547
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2023 | 150 | 475 | $72,200 | $14,375 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $13,738 | $2,496 | 18.2% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2022 | 266 | 849 | $126,507 | $26,843 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 39 | $20,670 | $4,049 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 25 | $18,611 | $3,841 | 20.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $15,039 | $3,220 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 42 | $11,991 | $2,555 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 25 | $9,975 | $1,646 | 16.5% |
| 85576 | Platelet aggregation function test | Facility | 2022 | 12 | 70 | $5,810 | $1,098 | 18.9% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2021 | 353 | 1,090 | $168,314 | $35,049 | 20.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 32 | $26,184 | $5,246 | 20.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 31 | 31 | $22,428 | $4,390 | 19.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 51 | $14,997 | $3,172 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 28 | $13,115 | $2,748 | 21.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 28 | 29 | $7,827 | $2,338 | 29.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $10,251 | $2,192 | 21.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 23 | 25 | $8,538 | $2,035 | 23.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 13 | $5,915 | $1,388 | 23.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $6,255 | $1,307 | 20.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 15 | $3,510 | $883.09 | 25.2% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2020 | 282 | 783 | $119,350 | $26,191 | 21.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 26 | 31 | $25,218 | $5,528 | 21.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 70 | $20,502 | $4,420 | 21.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 30 | 30 | $14,571 | $3,320 | 22.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 19 | 19 | $10,902 | $2,830 | 26.0% |
About Nathan Connell, MD, MPH
Nathan Connell, MD, MPH is a Hematology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245432467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nathan Connell, MD, MPH has received a total of $125,288 in payments from pharmaceutical and medical device companies, with $26,872 received in 2024. These payments were reported across 73 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($74,022).
As a Medicare-enrolled provider, Connell has provided services to 1,585 Medicare beneficiaries, totaling 3,924 services with total Medicare billing of $170,547. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology
- Location Boston, MA
- Active Since 06/01/2007
- Last Updated 01/10/2026
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1245432467
Products in Payments
- VONVENDI (Biological) $24,481
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) $19,512
- Hemlibra (Biological) $12,885
- HEMLIBRA (Biological) $7,119
- NUWIQ (Biological) $4,567
- BEQVEZ (Biological) $2,500
- Jivi (Drug) $1,136
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Boston
Jacalyn Rosenblatt, M.d, M.D
Hematology — Payments: $1.6M
Hematology $1.6M
Jorge Castillo, Md, MD
Hematology — Payments: $922,724
Hematology $922,724
Dr. Edward Benz, Md, MD
Hematology — Payments: $746,999
Hematology $746,999
Andrew Evens, Do, Ms, DO, MS
Hematology — Payments: $339,696
Hematology $339,696
Dr. Caron Jacobson, Md, MD
Hematology — Payments: $294,282
Hematology $294,282
Lynn Bry, Md, MD
Hematology — Payments: $285,993
Hematology $285,993